We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
(+5.9%)
Cap. Flow
-$501M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$417M |
| 2 |
Meta Platforms (Facebook)
META
|
+$383M |
| 3 |
Amazon
AMZN
|
+$308M |
| 4 |
Microsoft
MSFT
|
+$293M |
| 5 |
GE Aerospace
GE
|
+$263M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$312M |
| 2 |
Bank of America
BAC
|
+$292M |
| 3 |
ExxonMobil
XOM
|
+$274M |
| 4 |
lululemon athletica
LULU
|
+$238M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.05% |
| 2 | Technology | 14.35% |
| 3 | Consumer Discretionary | 13.97% |
| 4 | Financials | 9.9% |
| 5 | Industrials | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Frontier Group Holdings
ULCC
$1.36B
| $12.2M | 0.03% |
1,235,375
+1,124,596
| +1,015% | +$12.6M |
|
|
HCNE
627
DELISTED
Jaws Hurricane Acquisition Corp. Class A Common Stock
HCNE
| $12.1M | 0.03% |
1,191,735
| – | – |
|
628
PUT
iShares US Real Estate ETF
IYR
$4.74B
| $12M | 0.03% |
141,900
-69,000
| -33% | -$6.04M |
|
629
Freshworks
FRSH
$3.01B
| $12M | 0.03% |
783,451
+702,177
| +864% | +$10.6M |
|
630
Crown Castle
CCI
$32.8B
| $12M | 0.03% |
89,911
-2,813
| -3% | -$389K |
|
631
Celldex Therapeutics
CLDX
$2.78B
| $12M | 0.03% |
333,666
-333,083
| -50% | -$14.4M |
|
|
GES
632
DELISTED
Guess Inc
GES
| $12M | 0.03% |
614,488
+507,718
| +476% | +$10.9M |
|
633
Huntington Bancshares
HBAN
$34.9B
| $11.9M | 0.03% |
1,066,295
+911,155
| +587% | +$12.7M |
|
634
NVR
NVR
$17.3B
| $11.9M | 0.03% |
2,138
+1,957
| +1,081% | +$10.1M |
|
635
Bloom Energy
BE
$51.3B
| $11.9M | 0.03% |
596,883
-268,236
| -31% | -$5.87M |
|
|
AGR
636
DELISTED
Avangrid, Inc.
AGR
| $11.8M | 0.03% |
295,894
-286,046
| -49% | -$11.7M |
|
637
TechTarget
TTGT
$268M
| $11.8M | 0.03% |
326,491
-46,650
| -13% | -$1.95M |
|
638
CALL
Johnson & Johnson
JNJ
$646B
| $11.7M | 0.03% |
75,800
-168,600
| -69% | -$27.2M |
|
639
Lear
LEA
$7.18B
| $11.7M | 0.02% |
84,074
-97,344
| -54% | -$13.5M |
|
640
WD-40
WDFC
$3.15B
| $11.7M | 0.02% |
65,723
+58,719
| +838% | +$10.1M |
|
641
PUT
Danaher
DHR
$136B
| $11.7M | 0.02% |
52,226
+36,547
| +233% | +$8.31M |
|
642
Comstock Resources
CRK
$3.86B
| $11.7M | 0.02% |
1,081,329
-1,057,411
| -49% | -$12.6M |
|
643
Tyler Technologies
TYL
$13B
| $11.6M | 0.02% |
32,806
-223
| -0.7% | -$72.5K |
|
644
Harley-Davidson
HOG
$2.62B
| $11.6M | 0.02% |
+305,946
| New | +$13.4M |
|
645
Ascendis Pharma A/S
ASND
$16.8B
| $11.6M | 0.02% |
108,326
+4,900
| +5% | +$561K |
|
646
Carrier Global
CARR
$56.8B
| $11.6M | 0.02% |
252,902
-17,498
| -6% | -$783K |
|
647
Coca-Cola
KO
$361B
| $11.6M | 0.02% |
186,373
-1,288,668
| -87% | -$78M |
|
648
DaVita
DVA
$15.2B
| $11.5M | 0.02% |
141,970
-9,534
| -6% | -$764K |
|
649
CALL
UnitedHealth
UNH
$379B
| $11.4M | 0.02% |
24,200
-19,600
| -45% | -$9.46M |
|
650
Vipshop
VIPS
$7.1B
| $11.4M | 0.02% |
+753,002
| New | +$11.2M |
|
Similar funds
Marshall Wace's Q1 2023 Portfolio in Review
As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
- Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
- Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
- Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
- Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
- Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
- Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.
Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.